Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
F D'AntonioD MarinceuSmriti PrasadAsma KhalilPublished in: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology (2022)
Prenatal valacyclovir administration in pregnancies with maternal CMV infection can reduce the risk of congenital CMV infection. Further evidence is needed to elucidate whether valacyclovir can affect the course of the infection in the fetus and the risk of symptomatic fetal or neonatal infection. This article is protected by copyright. All rights reserved.